Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Odyssey HealthODYY -10.20% 3-Year EBITDA Growth Rate is 45.20% as of Apr. 2026. The stock has 4 warning signs investors should review. Among 692 Medical Devices & Instruments companies, Odyssey Health ranks better than 86.42% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 45.20% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 40.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -38.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Odyssey Health was 73.90% per year. The lowest was -593.80% per year. And the median was -36.00% per year.
Odyssey Health (OTCPK:ODYY) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Odyssey Health 3-Year EBITDA Growth Rate Related Terms
ODYY vs NUWE, RBOT, PFSA: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, Odyssey Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Odyssey Health 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Health's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Odyssey Health's 3-Year EBITDA Growth Rate falls into.
Odyssey Health 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 45.20% mean?
Odyssey Health (ODYY) has a 3-Year EBITDA Growth Rate of 45.20% as of Apr. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Odyssey Health and its competitors. According to the industry distribution chart, Odyssey Health ranks #94 out of 692 companies in the Medical Devices & Instruments industry, placing it in the top 13.6%.
Is Odyssey Health's 3-Year EBITDA Growth Rate too high?
Odyssey Health's current 3-Year EBITDA Growth Rate is 45.20%. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 8.20. Odyssey Health's value of 45.20% is 451.2% above this industry median. Based on the distribution chart, Odyssey Health ranks #94 out of 692 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Odyssey Health's 3-Year EBITDA Growth Rate compare to NUWE and RBOT?
According to the Medical Devices & Instruments industry distribution chart, Odyssey Health ranks #94 out of 692 companies for 3-Year EBITDA Growth Rate. This places Odyssey Health in the top 14% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 8.20. Odyssey Health's value of 45.20% is 451.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.20, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Odyssey Health's current 3-Year EBITDA Growth Rate of 45.20% is 451.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Odyssey Health and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Odyssey Health's current 3-Year EBITDA Growth Rate is 45.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Health stock overvalued right now?
Odyssey Health (ODYY) has a current 3-Year EBITDA Growth Rate of 45.20%. The current 3-Year EBITDA Growth Rate is 45.20% and 451.2% above the Medical Devices & Instruments industry median of 8.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Odyssey Health (ODYY), the current 3-Year EBITDA Growth Rate is 45.20% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ODYY has been successfully added to your 
